Utility of a fluorescence microscopy imaging system for analyzing the DNA ploidy of pathological megakaryocytes including 5q- syndrome

Takako Nakahara, Shin ichiro Suemori, Takayuki Tsujioka, Mikio Kataoka, Hiromi Kataoka, Misako Shibakura, Kaoru Tohyama

Research output: Contribution to journalArticle

Abstract

To investigate megakaryocyte (MK) DNA ploidy in various hematological diseases, fluorescence microscopy imaging system (FMI) can be used to analyze DNA ploidy with cell morphology at the single-cell level by using specialized image-processing software. Here we compared DNA ploidy obtained by FMI measured with that obtained flow cytometry (FCM). With FMI, we could evaluate the DNA ploidy in long-term preserved bone marrow smear samples after staining. We next analyzed the MK DNA ploidy in 42 bone marrow smear samples including 26 myeloid neoplasm cases, and we compared the DNA ploidy and platelet counts in the patients' peripheral blood; the production of platelets was significantly high compared to DNA ploidy in the myeloproliferative neoplasms group. The FMI method revealed that the patients with 5q- syndrome exhibited relatively low DNA ploidy despite high platelet counts, and this result suggested that increased DNA ploidy is not indispensable to abundant platelet production. The FMI method for DNA ploidy will be a useful tool to clarify the relationship between DNA ploidy and platelet production by MKs.

Original languageEnglish
Pages (from-to)249-256
Number of pages8
JournalActa Medica Okayama
Volume72
Issue number3
Publication statusPublished - Jan 1 2018

Fingerprint

Megakaryocytes
Ploidies
Fluorescence microscopy
Optical Imaging
Fluorescence Microscopy
Imaging systems
DNA
Platelets
Blood Platelets
Platelet Count
Bone
Chromosome 5q Deletion Syndrome
Bone Marrow
Flow cytometry
Hematologic Diseases
Neoplasms
Flow Cytometry
Image processing
Blood
Software

Keywords

  • 5q- syndrome
  • DNA ploidy
  • Fluorescence microscopy image analysis
  • MDS with isolated del(5q)
  • Megakaryocytes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Nakahara, T., Suemori, S. I., Tsujioka, T., Kataoka, M., Kataoka, H., Shibakura, M., & Tohyama, K. (2018). Utility of a fluorescence microscopy imaging system for analyzing the DNA ploidy of pathological megakaryocytes including 5q- syndrome. Acta Medica Okayama, 72(3), 249-256.

Utility of a fluorescence microscopy imaging system for analyzing the DNA ploidy of pathological megakaryocytes including 5q- syndrome. / Nakahara, Takako; Suemori, Shin ichiro; Tsujioka, Takayuki; Kataoka, Mikio; Kataoka, Hiromi; Shibakura, Misako; Tohyama, Kaoru.

In: Acta Medica Okayama, Vol. 72, No. 3, 01.01.2018, p. 249-256.

Research output: Contribution to journalArticle

Nakahara, T, Suemori, SI, Tsujioka, T, Kataoka, M, Kataoka, H, Shibakura, M & Tohyama, K 2018, 'Utility of a fluorescence microscopy imaging system for analyzing the DNA ploidy of pathological megakaryocytes including 5q- syndrome', Acta Medica Okayama, vol. 72, no. 3, pp. 249-256.
Nakahara, Takako ; Suemori, Shin ichiro ; Tsujioka, Takayuki ; Kataoka, Mikio ; Kataoka, Hiromi ; Shibakura, Misako ; Tohyama, Kaoru. / Utility of a fluorescence microscopy imaging system for analyzing the DNA ploidy of pathological megakaryocytes including 5q- syndrome. In: Acta Medica Okayama. 2018 ; Vol. 72, No. 3. pp. 249-256.
@article{acf8d787f3de4a1d93af8806a4e4029d,
title = "Utility of a fluorescence microscopy imaging system for analyzing the DNA ploidy of pathological megakaryocytes including 5q- syndrome",
abstract = "To investigate megakaryocyte (MK) DNA ploidy in various hematological diseases, fluorescence microscopy imaging system (FMI) can be used to analyze DNA ploidy with cell morphology at the single-cell level by using specialized image-processing software. Here we compared DNA ploidy obtained by FMI measured with that obtained flow cytometry (FCM). With FMI, we could evaluate the DNA ploidy in long-term preserved bone marrow smear samples after staining. We next analyzed the MK DNA ploidy in 42 bone marrow smear samples including 26 myeloid neoplasm cases, and we compared the DNA ploidy and platelet counts in the patients' peripheral blood; the production of platelets was significantly high compared to DNA ploidy in the myeloproliferative neoplasms group. The FMI method revealed that the patients with 5q- syndrome exhibited relatively low DNA ploidy despite high platelet counts, and this result suggested that increased DNA ploidy is not indispensable to abundant platelet production. The FMI method for DNA ploidy will be a useful tool to clarify the relationship between DNA ploidy and platelet production by MKs.",
keywords = "5q- syndrome, DNA ploidy, Fluorescence microscopy image analysis, MDS with isolated del(5q), Megakaryocytes",
author = "Takako Nakahara and Suemori, {Shin ichiro} and Takayuki Tsujioka and Mikio Kataoka and Hiromi Kataoka and Misako Shibakura and Kaoru Tohyama",
year = "2018",
month = "1",
day = "1",
language = "English",
volume = "72",
pages = "249--256",
journal = "Acta Medica Okayama",
issn = "0386-300X",
publisher = "Okayama University",
number = "3",

}

TY - JOUR

T1 - Utility of a fluorescence microscopy imaging system for analyzing the DNA ploidy of pathological megakaryocytes including 5q- syndrome

AU - Nakahara, Takako

AU - Suemori, Shin ichiro

AU - Tsujioka, Takayuki

AU - Kataoka, Mikio

AU - Kataoka, Hiromi

AU - Shibakura, Misako

AU - Tohyama, Kaoru

PY - 2018/1/1

Y1 - 2018/1/1

N2 - To investigate megakaryocyte (MK) DNA ploidy in various hematological diseases, fluorescence microscopy imaging system (FMI) can be used to analyze DNA ploidy with cell morphology at the single-cell level by using specialized image-processing software. Here we compared DNA ploidy obtained by FMI measured with that obtained flow cytometry (FCM). With FMI, we could evaluate the DNA ploidy in long-term preserved bone marrow smear samples after staining. We next analyzed the MK DNA ploidy in 42 bone marrow smear samples including 26 myeloid neoplasm cases, and we compared the DNA ploidy and platelet counts in the patients' peripheral blood; the production of platelets was significantly high compared to DNA ploidy in the myeloproliferative neoplasms group. The FMI method revealed that the patients with 5q- syndrome exhibited relatively low DNA ploidy despite high platelet counts, and this result suggested that increased DNA ploidy is not indispensable to abundant platelet production. The FMI method for DNA ploidy will be a useful tool to clarify the relationship between DNA ploidy and platelet production by MKs.

AB - To investigate megakaryocyte (MK) DNA ploidy in various hematological diseases, fluorescence microscopy imaging system (FMI) can be used to analyze DNA ploidy with cell morphology at the single-cell level by using specialized image-processing software. Here we compared DNA ploidy obtained by FMI measured with that obtained flow cytometry (FCM). With FMI, we could evaluate the DNA ploidy in long-term preserved bone marrow smear samples after staining. We next analyzed the MK DNA ploidy in 42 bone marrow smear samples including 26 myeloid neoplasm cases, and we compared the DNA ploidy and platelet counts in the patients' peripheral blood; the production of platelets was significantly high compared to DNA ploidy in the myeloproliferative neoplasms group. The FMI method revealed that the patients with 5q- syndrome exhibited relatively low DNA ploidy despite high platelet counts, and this result suggested that increased DNA ploidy is not indispensable to abundant platelet production. The FMI method for DNA ploidy will be a useful tool to clarify the relationship between DNA ploidy and platelet production by MKs.

KW - 5q- syndrome

KW - DNA ploidy

KW - Fluorescence microscopy image analysis

KW - MDS with isolated del(5q)

KW - Megakaryocytes

UR - http://www.scopus.com/inward/record.url?scp=85048880681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048880681&partnerID=8YFLogxK

M3 - Article

C2 - 29926002

AN - SCOPUS:85048880681

VL - 72

SP - 249

EP - 256

JO - Acta Medica Okayama

JF - Acta Medica Okayama

SN - 0386-300X

IS - 3

ER -